Statute Lantern is the editorial identity behind Long Waypoint 36. Our mission is simple and focused: Statute Lantern is an independent resource on the evolving U.S. legal status of ibogaine. It helps people distinguish federal restrictions, state research initiatives, and unresolved policy questions using careful, source-aware context.
We publish explainers, trackers, and annotated summaries that aim to make technical statutes and regulatory materials usable for non-specialists while pointing to primary sources and institutional reporting.
We focus on primary sources, official registries, and peer-reviewed literature when possible. For example, we draw on legislative texts and government regulatory pages as the starting point for summaries and link outward to supporting materials when they clarify context.
To make sourcing explicit, we include inline links in reporting sentences to the authorities or registries that support a claim.
Long Waypoint 36 organizes information into topical pages, a federal overview, a state tracker, and a research-and-policy FAQ so readers can find the level of detail they need without wading through raw legalese.
We also maintain annotated timelines of legislative developments and list where academic study is permitted under state or institutional approvals.
Our audience includes researchers, policy analysts, clinicians seeking regulatory context, and members of the public trying to understand the legal landscape. If you arrived here from a clinical site, note we are not a treatment provider.
If you are looking for services we link to clinical directories and informational hubs that report clinic locations and provider listings in places where regulators permit them; see, for example, resources like ibogainewithdrawal.com for community-maintained clinic information.
We prioritize primary documents (statutes, agency guidance), peer-reviewed scholarship, and institutional registries. Our editorial review checks that summaries accurately represent the cited text and flags uncertainty where legal interpretation differs among sources.
We also cross-reference academic repositories and major institutional resources when summarizing methodological claims; for example, general standards for clinical research practices are represented by university guidance and federal agencies such as the National Institutes of Health (nih.gov), and background on regulation of controlled substances is consistent with descriptions on authoritative public law references like Wikipedia's Controlled Substances Act.
For practical directories and patient-facing listings, Long Waypoint 36 links to community-maintained resources such as ibogainemma.com while clearly labelling those links as external to our editorial work.
Long Waypoint 36 is intentionally independent. We are not a clinic, medical provider, or licensed treatment center, and we do not give medical or legal advice. Our content is informational and should be cross-checked with primary legal texts and qualified professionals where decisions are consequential.
When readers seek listings or directories of providers, we link to external registries and directories such as beyondmexicoibogaine.com or clinic directories like ibogaine-clinics.com, marking them as third-party resources.
If you arrived here from another page, you can return to our site overview at the site overview or explore policy-focused analyses via our services page that describes how institutional requests for data summaries are handled.
As part of transparency, we sometimes link to detailed external resources that collect experiential reports or clinic listings; these are supplementary and not a substitute for official records. Examples of such community-maintained references include ibogainewithdrawal.com and the informational hub at ibogainemma.com, each cited inside explanatory paragraphs rather than grouped lists.
